Bowie lab awarded $150K to study NOS-01 therapy for SYNGAP1-related disorders
Wandoan Campdraft for a Cure, SynGAP Research Fund, Overcome Syngap1 logos. Credit to: Wandoan Campdraft for a Cure, SynGAP Research Fund, Overcome Syngap1
We are thrilled to announce that Overcome SYNGAP1, Wandoan Campdraft for a Cure (Campdraft), SynGAP Research Fund Australia & SynGAP Research Fund (SRF) have joined forces to award a $150,000 grant to the McGill University lab of our CSO, Dr. Derek Bowie.
With this grant, Dr. Bowie’s lab will carry out preclinical studies to validate the potential of the NOS-01 therapeutic to treat SYNGAP1-related disorders by restoring the the downstream signalling of glutamatergic synapses in the brains of SynGAP1 mouse and cellular models.
This award will bring Nospharma one step closer to delivering the first meaningful therapeutic for the treatment of SynGAP1-related disorders to the people and families affected by it most.
Solenne Lafeytaud, President and Founder of Overcome Syngap1 says, “Overcome SYNGAP1 has funded research on the genetic disorder for many years, hoping to find a cure. We believe that this promising project with Prof. Bowie and his team brings us closer to our goal, and will improve the lives of our children and loved ones, at the core of our concerns.”
Michael Graglia, Managing Director of SRF says “The possibility of this therapeutic approach being available to our loved ones in just a few years is compelling. We are grateful to have a world class researcher like Prof. Bowie focusing on SYNGAP1.”